Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCN9A | Q15858 | 20/20 | 0.59 |
| ▸ | SCN7A | Q01118 | 1/20 | 0.59 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.59 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.59 |
| ▸ | SCN8A | Q9UQD0 | 1/20 | 0.59 |
| ▸ | SCN10A | Q9Y5Y9 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL281663 | 0.89 | SCN9A (0.75) | SCN9ASCN7ASCN5ASCN2ASCN8A | |
| SCHEMBL4730724 | 0.85 | SCN9A (0.81) | SCN9ASCN7ASCN5ASCN2ASCN8A | |
| SCHEMBL4729017 | 0.83 | SCN9A (0.54) | SCN9ASCN7ASCN5ASCN2ASCN8A | |
| SCHEMBL14221300 | 0.80 | SCN9A (0.52) | SCN9ASCN7ASCN5ASCN2ASCN8A | |
| SCHEMBL4729265 | 0.79 | SCN9A (0.52) | SCN9ASCN7ASCN5ASCN2ASCN8A | |
| SCHEMBL18212642 | 0.77 | SCN9A (0.78) | SCN9ASCN7ASCN5ASCN2ASCN8A | |
| SCHEMBL281517 | 0.77 | SCN9A (0.75) | SCN9ASCN7ASCN5ASCN2ASCN8A | |
| SCHEMBL281220 | 0.77 | SCN9A (0.75) | SCN9ASCN7ASCN5ASCN2ASCN8A | |
| SCHEMBL12712131 | 0.77 | SCN9A (0.75) | SCN9ASCN7ASCN5ASCN2ASCN8A | |
| SCHEMBL12712134 | 0.77 | SCN9A (0.75) | SCN9ASCN7ASCN5ASCN2ASCN8A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008046087-A2 | SPIRO COMPOUNDS AND THEIR USES AS THERAPEUTIC AGENTS | XENON PHARMACEUTICALS INC. (CA) | 2008-04-17 | — | — | WO | claimed |
| WO-2008046087-A2 | SPIRO COMPOUNDS AND THEIR USES AS THERAPEUTIC AGENTS | XENON PHARMACEUTICALS INC. (CA) | 2008-04-17 | — | — | WO | disclosed |